Allergy Therapeutics
AGY.L
#6280
Rank
NZ$1.44 B
Marketcap
NZ$0.24
Share price
-4.65%
Change (1 day)
70.04%
Change (1 year)

Earnings for Allergy Therapeutics (AGY.L)

Earnings in 2024: -NZ$85.28 Million

According to Allergy Therapeutics's latest financial reports the company's current earnings are NZ$69.81 Million. In 2024 the company made an earning of -NZ$85.28 Million, an increase over its 2023 earnings that were of -NZ$91.4 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Allergy Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024-NZ$85.28 Million-6.69%
2023-NZ$91.4 Million244.94%
2022-NZ$26.5 Million-404.35%
2021NZ$8.7 M-49.42%
2020NZ$17.21 M83.48%
2019NZ$9.38 M-159.83%
2018-NZ$15.69 Million255.48%
2017-NZ$4.42 Million-84.06%
2016-NZ$27.68 Million-1667.33%
2015NZ$1.76 M-44.68%
2014NZ$3.19 M130.59%
2013NZ$1.38 M-19.89%
2012NZ$1.72 M-127.05%
2011-NZ$6.39 Million2009.96%
2010-NZ$0.31 Million-99.07%
2009-NZ$32.45 Million-53.23%
2008-NZ$69.37 Million-21.86%
2007-NZ$88.78 Million356.94%
2006-NZ$19.43 Million230.75%
2005-NZ$5.88 Million-217.9%
2004NZ$4.98 M-58.79%
2003NZ$12.08 M-196.03%
2002-NZ$12.59 Million